Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-24-001974

Options or other derivatives

  • Chief Executive Officer acquired 1,545,252 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Collard Craig A · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-01-19 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +1,324,502 1,324,502 D
2024-01-19 Grant or award : show line 2 in the form Restricted Stock Units +220,750 220,750 D
Loading xslF345X05/doc4.xml…